Skip to main content
Log in

Mifepristone increases AQP1 mRNA expression, angiogenesis, and cell permeability through the ERK MAPK pathway

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Aims

The purpose of this study was to investigate the mechanism of mifepristone serves as an anti-implantation contraceptive drug on aquaporins 1 (AQP1) expression.

Methods

Human umbilical vein endothelial cells (HUVECs) were used to detect the effects of different concentrations of mifepristone (0, 0.065, 0.2, and 1 μmol/L) on the activity of angiogenesis and AQP1 expression. The expression of AQP1 was tested by the real-time PCR. The angiogenesis and penetration function of HUVECs was investigated by Matrigel lumen formation and trans-well assay, respectively.

Results

The expression of AQP1, angiogenesis and cell permeability were significantly higher than control groups in HUVECs treatment with mifepristone at 1 μmol/L for 12 h. Estrogen and progesterone decreased the up-regulation of AQP1 and cell permeability, not angiogenesis, induced by mifepristone. Mifepristone increased protein levels of p-ERK, not p-p38 or p-JNK, and pre-treatment with ERK MAPK-specific inhibitor significantly inhibited the up-regulation of AQP1 mRNA expression, angiogenesis and cell permeability induced by mifepristone. si-AQP1 significantly reduced the up-regulation of angiogenesis, cell permeability and p-ERK/ERK ratio expression induced by mifepristone treatment. Overexpression of AQP1 enhanced the increase of expression ratio of p-ERK/ERK induced by mifepristone.

Conclusions

Low-dose mifepristone increased cell permeability, angiogenesis and AQP1 expression, which was involved in MAPK pathways. This provides new insights into the molecular mechanism of mifepristone serves as an anti-implantation contraceptive drug.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Navot D, Bergh P (1991) Preparation of the human endometrium for implantation. Ann N Y Acad Sci 622:212–219

    Article  CAS  Google Scholar 

  2. Benga G (2012) The first discovered water channel protein, later called aquaporin 1: molecular characteristics, functions and medical implications. Mol Aspects Med 33:518–534

    Article  CAS  Google Scholar 

  3. Zhang D, Tan YJ, Qu F, Sheng JZ, Huang HF (2012) Functions of water channels in male and female reproductive systems. Mol Aspects Med 33:676–690

    Article  CAS  Google Scholar 

  4. Feng C, Sun CC, Wang TT, He RH, Sheng JZ, Huang HF (2008) Decreased expression of endometrial vessel AQP1 and endometrial epithelium AQP2 related to anovulatory uterine bleeding in premenopausal women. Menopause 15:648–654

    Article  Google Scholar 

  5. Mullertz KM, Strom C, Trautner S, Amtorp O, Nielsen S, Christensen S, Haunso S, Jonassen TE (2011) Downregulation of aquaporin-1 in alveolar microvessels in lungs adapted to chronic heart failure. Lung 189:157–166

    Article  Google Scholar 

  6. Saadoun S, Papadopoulos MC, Davies DC, Bell BA, Krishna S (2002) Increased aquaporin 1 water channel expression in human brain tumours. Br J Cancer 87:621–623

    Article  CAS  Google Scholar 

  7. Huebert RC, Vasdev MM, Shergill U, Das A, Huang BQ, Charlton MR, LaRusso NF, Shah VH (2010) Aquaporin-1 facilitates angiogenic invasion in the pathological neovasculature that accompanies cirrhosis. Hepatology 52:238–248

    Article  CAS  Google Scholar 

  8. Saadoun S, Papadopoulos MC, Hara-Chikuma M, Verkman AS (2005) Impairment of angiogenesis and cell migration by targeted aquaporin-1 gene disruption. Nature 434:786–792

    Article  CAS  Google Scholar 

  9. Huebert RC, Jagavelu K, Hendrickson HI, Vasdev MM, Arab JP, Splinter PL, Trussoni CE, Larusso NF, Shah VH (2011) Aquaporin-1 promotes angiogenesis, fibrosis, and portal hypertension through mechanisms dependent on osmotically sensitive microRNAs. Am J Pathol 179:1851–1860

    Article  CAS  Google Scholar 

  10. Zhao W, Shen H, Yuan F, Li G, Sun Y, Shi Z, Zhang Y, Wang Z (2009) Induction stage-dependent expression of vascular endothelial growth factor and aquaporin-1 in diethylstilbestrol-treated rat pituitary. Eur J Histochem 53:53–60

    Article  CAS  Google Scholar 

  11. Lindsay LA, Murphy CR (2004) Redistribution of aquaporins in uterine epithelial cells at the time of implantation in the rat. Acta Histochem 106:299–307

    Article  CAS  Google Scholar 

  12. Comparison of three single doses of mifepristone as emergency contraception: a randomised trial. Task Force on Postovulatory Methods of Fertility Regulation. Lancet 1999, 353:697–702

  13. Chen Y, Wang W, Zhuang Y, Chen X, Huang L (2011) Effects of low-dose mifepristone administration in two different 14-day regimens on the menstrual cycle and endometrial development: a randomized controlled trial. Contraception 84:64–70

    Article  CAS  Google Scholar 

  14. Zhou F, Liang Y, Qian ZD, Zhuang YL, Chen YZ, Lv BJ, Zhou CY, Chen XD, Huang LL (2013) Low-dose mifepristone increases uterine expression of aquaporin 1/aquaporin 2 at the time of implantation. Contraception 87:844–849

    Article  CAS  Google Scholar 

  15. Zhou F, Qian Z, Huang L (2019) Low-dose mifepristone increased angiogenesis in a manner involving AQP1. Arch Gynecol Obstet 299:579–584

    Article  CAS  Google Scholar 

  16. Zhang G, Han H, Zhuge Z, Dong F, Jiang S, Wang W, Guimaraes DD, Schiffer TA, Lai EY, Ribeiro-Antonino-Carvalho LR, Lucena RB, Braga VA, Weitzberg E, Lundberg JO, Carlstrom M (2021) Renovascular effects of inorganic nitrate following ischemia-reperfusion of the kidney. Redox Biol 39:101836

    Article  CAS  Google Scholar 

  17. Zhang G, Wang Q, Wang W, Yu M, Zhang S, Xu N, Zhou S, Cao X, Fu X, Ma Z, Liu R, Mao J, Lai EY (2018) Tempol protects against acute renal injury by regulating PI3K/Akt/mTOR and GSK3beta signaling cascades and afferent arteriolar activity. Kidney Blood Press Res 43:904–913

    Article  CAS  Google Scholar 

  18. Kim Y, Lee S, Zhang H, Lee S, Kim H, Kim Y, Won MH, Kim YM, Kwon YG (2020) CLEC14A deficiency exacerbates neuronal loss by increasing blood-brain barrier permeability and inflammation. J Neuroinflammation 17:48

    Article  CAS  Google Scholar 

  19. Tinsley JH, Teasdale NR, Yuan SY (2004) Involvement of PKCdelta and PKD in pulmonary microvascular endothelial cell hyperpermeability. Am J Physiol Cell Physiol 286:C105–C111

    Article  CAS  Google Scholar 

  20. Croxatto HB, Kovacs L, Massai R, Resch BA, Fuentealba B, Salvatierra AM, Croxatto HD, Zalanyi S, Viski S, Krenacs L (1998) Effects of long-term low-dose mifepristone on reproductive function in women. Hum Reprod 13:793–798

    Article  CAS  Google Scholar 

  21. Ghosh D, Sengupta J (1993) Anti-nidatory effect of a single, early post-ovulatory administration of mifepristone (RU 486) in the rhesus monkey. Hum Reprod 8:552–558

    Article  CAS  Google Scholar 

  22. Mahajan DK, London SN (1997) Mifepristone (RU486): a review. Fertil Steril 68:967–976

    Article  CAS  Google Scholar 

  23. Hildenbrand A, Stavreus-Evers A, Lalitkumar PG, Nielsen S, Mints M, Gemzell-Danielsson K (2008) Aquaporin 1 is expressed in the human endometrium during normal cycle and increases after mifepristone treatment. Int J Mol Med 22:49–53

    CAS  Google Scholar 

  24. Yang M, Gao F, Liu H, Yu WH, Zhuo F, Qiu GP, Ran JH, Sun SQ (2013) Hyperosmotic induction of aquaporin expression in rat astrocytes through a different MAPK pathway. J Cell Biochem 114:111–119

    Article  CAS  Google Scholar 

  25. Liu L, Xie C (2011) Effects of downregulation of aquaporin1 by peptidoglycan and lipopolysaccharide via MAPK pathways in MeT-5A cells. Lung 189:331–340

    Article  CAS  Google Scholar 

  26. Zou LB, Shi S, Zhang RJ, Wang TT, Tan YJ, Zhang D, Fei XY, Ding GL, Gao Q, Chen C, Hu XL, Huang HF, Sheng JZ (2013) Aquaporin-1 plays a crucial role in estrogen-induced tubulogenesis of vascular endothelial cells. J Clin Endocrinol Metab 98:E672–E682

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Funding was provided by National Natural Science Foundation of China (Grant No.: 81701502).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yuezhou Chen or Feng Zhou.

Ethics declarations

Conflict of interest

The authors of this manuscript state that they do not have any conflict of interests and nothing to disclose.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, W., Kang, Y., Jiang, Y. et al. Mifepristone increases AQP1 mRNA expression, angiogenesis, and cell permeability through the ERK MAPK pathway. Mol Biol Rep 50, 1069–1077 (2023). https://doi.org/10.1007/s11033-022-08082-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-022-08082-w

Keywords

Navigation